ABSTRACT Group B Streptococcus (GBS) is a pervasive neonatal pathogen accounting for
a combined half a million deaths and stillbirths annually. The most common source of fetal or …

Group B Streptococcus (GBS) is a leading cause of neonatal sepsis and an important cause
of maternal disease in many countries; however, no accurate population-based …

Streptococcus agalactiae (also known Group B Streptococcus or GBS) represents the main
pathogen responsible for early-and late-onset infections in newborns. The present study …

Group B Streptococcus (GBS; Streptococcus agalactiae) is a major neonatal and
opportunistic bacterial pathogen of humans and an important cause of mastitis in dairy cattle …

Invasive disease owing to group B Streptococcus (GBS) is a major cause of illness and
death among newborns. Maternal GBS colonization of gastrointestinal tract and/or vagina is …

Background Colonization and transmission precede invasive group B streptococcal (GBS)
disease. Data on GBS colonization prevalence, detection methods and risk factors for …

Abstract Background Group B streptococcus (GBS) is the leading cause of early-onset
neonatal sepsis. However, GBS was infrequently reported in the developing world in …

Background and purpose To reduce the resistance and allergic reaction to chlorhexidine
acetate (CHA) in the current treatment of (Bacterial vaginosis) BV and (vulvovaginal …

Background Nationwide group B Streptococcus agalactiae (GBS) antepartum screening was
instituted in Taiwan in 2012. The impact of the policy on early-onset sepsis (EOS) has not …

Abstract Background Streptococcus agalctiae (Group B Streptococcus, GBS) is a perinatal
pathogen and a leading cause of neonatal infections worldwide. Serotype, sequence type …